Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Añadir filtros








Intervalo de año
7.
Southeast Asian J Trop Med Public Health ; 1983 Dec; 14(4): 488-90
Artículo en Inglés | IMSEAR | ID: sea-30915

RESUMEN

A seroepidemiology of measles hemagglutination inhibition antibody was studied in infants at birth to 8 months of age. It was found that at birth the antibody was greater than 1:8 in 56 of 64 newborns. At 2 and 4 months of age, 9 of 21 and 12 of 21 respectively had measles antibody titer less than 1:8, while at 8 months of age, only 1 of 6 had the antibody titer greater than 1:8. It shows that the maternal measles antibody can protect the infant at young age and the decrease in antibodies occur as the child grows. The measles vaccine should be given when the maternal passive immunity of measles disappears. This study indicates that the optimal age to recommend measles vaccination should be at the age of 9 months.


Asunto(s)
Anticuerpos Antivirales/análisis , Pruebas de Inhibición de Hemaglutinación , Humanos , Esquemas de Inmunización , Lactante , Recién Nacido , Sarampión/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA